| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 10:00-10:06 |
TACE-HAIC plus targeted therapy and immunotherapy for HCC with tumor thrombus and arteriovenous fistula |
Xue-Song Liu | Harbin Medical University Cancer Hospital, China |
| 2 | 10:08-10:14 |
Study on pathogenesis of posterior reversible encephalopathy syndrome after TACE of liver cancer |
Ke-Feng Jia | Tianjin Third Central Hospital, China |
| 3 | 10:16-10:22 |
Microbial metabolism dysfunction induced by transarterial chemoembolization aggravates postprocedural liver injury in HCC |
Li-Teng Lin | The Second Affiliated Hospital of Guangzhou Medical University, China |
| 4 | 10:24-10:30 |
Lactate-Modulating Pickering Emulsion Facilitate Self-Amplifying Pyroptosis and the cGAS-STING Cascade for TACE Therapy |
Lin-Zhu Zhang | Zhongda Hospital, Southeast University, China |
| 5 | 10:32-10:38 |
Prediction and assessment of response to Trans-Arterial Chemoembolization (TACE) in patients with Hepatocellular Carcinoma (HCC) using Diffusion Weighted Magnetic Resonance Imaging (DWI MRI). |
waseem sajjad | Saleem Memorial Hospital, Lahore, Pakistan |
| 6 | 10:40-10:46 |
Transarterial Chemoembolization With Nab-Paclitaxel for Breast Cancer Liver Metastases: Impact on Local Tumor Control and Survival |
Shahram Akhlaghpour | Pardis Noor Medical Imaging and Cancer Center, Iran |
| 7 | 10:48-10:54 |
Development and validation of the NTAA prognostic model for BCLC stage B hepatocellular carcinoma undergoing transarterial chemoembolization: a retrospective multicenter cohort study |
Shuang-Gang Chen | Sun yat-sen university cancer center, China |
| 8 | 10:56-11:02 |
Transarterial Chemoembolization Combined with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma and Child-Pugh B7 |
Chen-You Liu | The First Affiliated Hospital of Soochow University, China |
| 9 | 11:04-11:10 |
A real-world study on the treatment of advanced hepatocellular carcinoma with hepatic artery infusion chemotherapy combined with PD-1/PD-L1 inhibitors and molecular targeted drugs |
Yu-Qing Xu | Tianjin Medical University Cancer Institute & Hospital, China |
| 10 | 11:12-11:18 |
Drug-eluting beads bronchial arterial chemoembolization in advanced and standard treatment-refractory/ineligible non-small cell lung cancer |
Wei Cui | Guangdong Provincial People's Hospital, China |